The business of clinical trials is booming. Private equity has taken notice.

By Kaiser Health News
| December 02, 2022

Private equity firms have moved aggressively into the healthcare industry's more hidden niches: They are pouring billions into the business of clinical drug trials.

Full story

#1

Recent research on Paxlovid shows there is "solid data on its effectiveness," a co-author of the study told HealthLeaders. ...

A new personal protective equipment manufacturing company is set to open in Cincinnati next year. ...